Cargando…

EZH2 Expression in Retinoblastoma: A Potential Therapeutic Target

INTRODUCTION: The enhancer of zeste homolog 2 (EZH2) is a member of the polycomb repressive complex 2 (PRC2) and is important in cell-cycle regulation. Increased expression of EZH2 has been reported in retinoblastoma (RB). The aim of the study was to determine EZH2 expression, compare this with clin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Zhuangling, Tang, Lijuan, Chen, Shuxia, Zhang, Wenxin, Lin, Jianxian, Gao, Huanhuan, Zhang, Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	S. Karger AG 2023
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357381/ https://www.ncbi.nlm.nih.gov/pubmed/37311441 http://dx.doi.org/10.1159/000531530

Ejemplares similares

p16(INK4a) expression in retinoblastoma: a marker of differentiation grade
por: Liu, Yue, et al.
Publicado: (2014)

Detection of Epstein-Barr Virus in 130 Cases of Eyelid Sebaceous Gland Carcinoma Using In Situ Hybridization
por: Gao, Huanhuan, et al.
Publicado: (2020)

Antitumor activity of celastrol nanoparticles in a xenograft retinoblastoma tumor model
por: Li, Zhanrong, et al.
Publicado: (2012)

Characterization and Pharmacologic Targeting of EZH2, a Fetal Retinal Protein and Epigenetic Regulator, in Human Retinoblastoma
por: Khan, Mehnaz, et al.
Publicado: (2015)

MicroRNA-101-3p inhibits proliferation in retinoblastoma cells by targeting EZH2 and HDAC9
por: Jin, Qifang, et al.
Publicado: (2018)

Centromere protein E as a novel biomarker and potential therapeutic target for retinoblastoma
por: Shi, Ke, et al.
Publicado: (2021)

Regulation of TRAIL expression by PRAME and EZH2 as potential therapeutic target against solid tumors
por: Mello, Barbara P, et al.
Publicado: (2013)

Heavenly HELLS? A potential new therapeutic target for retinoblastoma
por: Zocchi, Loredana, et al.
Publicado: (2020)

Histone Methyltransferase EZH2: A Potential Therapeutic Target for Kidney Diseases
por: Li, Tingting, et al.
Publicado: (2021)

Targeting the EZH2-PPAR Axis Is a Potential Therapeutic Pathway for Pancreatic Cancer
por: Hu, Jilong, et al.
Publicado: (2021)

EZH2: novel therapeutic target for human cancer
por: Li, Long-Yuan
Publicado: (2014)

Therapeutic Targeting PLK1 by ON-01910.Na Is Effective in Local Treatment of Retinoblastoma
por: Ma, Huan, et al.
Publicado: (2021)

Aurora Kinase B Expression, Its Regulation and Therapeutic Targeting in Human Retinoblastoma
por: Borah, Naheed Arfin, et al.
Publicado: (2021)

EZH2 in Bladder Cancer, a Promising Therapeutic Target
por: Martínez-Fernández, Mónica, et al.
Publicado: (2015)

EZH2 in hepatocellular carcinoma: progression, immunity, and potential targeting therapies
por: Wang, Bohan, et al.
Publicado: (2023)

Resistance to BRAF Inhibitors: EZH2 and Its Downstream Targets as Potential Therapeutic Options in Melanoma
por: Uebel, Anne, et al.
Publicado: (2023)

EZH2 as a Potential Target for NAFLD Therapy
por: Lim, Hyun Jung, et al.
Publicado: (2020)

Single-cell characterization of malignant phenotypes and microenvironment alteration in retinoblastoma
por: Wu, Cheng, et al.
Publicado: (2022)

Role of EZH2 in Epithelial Ovarian Cancer: From Biological Insights to Therapeutic Target
por: Li, Hua, et al.
Publicado: (2013)

Targeting EZH1 and EZH2 contributes to the suppression of fibrosis-associated genes by miR-214-3p in cardiac myofibroblasts
por: Zhu, Wen-Si, et al.
Publicado: (2016)

UHRF1 is an Independent Prognostic Factor and a Potential Therapeutic Target of Esophageal Squamous Cell Carcinoma
por: Ye, Jiecheng, et al.
Publicado: (2017)

Targeting EZH2 as a novel therapeutic strategy for sorafenib‐resistant thyroid carcinoma
por: Wang, Zhengshi, et al.
Publicado: (2019)

EZH2-mediated H3K27me3 is a predictive biomarker and therapeutic target in uveal melanoma
por: Hou, Chen, et al.
Publicado: (2022)

The polycomb group protein EZH2 is a novel therapeutic target in tongue cancer
por: Li, Zhongwu, et al.
Publicado: (2013)

Expression of EZH2 is associated with poor outcome in colorectal cancer
por: Chen, Zhuanpeng, et al.
Publicado: (2018)

Dual targeting of EZH1 and EZH2 for the treatment of malignant rhabdoid tumors
por: Shinohara, Haruka, et al.
Publicado: (2022)

EZH2 as a therapeutic target for multiple myeloma and other haematological malignancies
por: Tremblay-LeMay, Rosemarie, et al.
Publicado: (2018)

Overexpression of EZH2 in conjunctival melanoma offers a new therapeutic target
por: Cao, Jinfeng, et al.
Publicado: (2018)

EZH2 presents a therapeutic target for neuroendocrine tumors of the small intestine
por: Barazeghi, Elham, et al.
Publicado: (2021)

Are BCL6 and EZH2 novel therapeutic targets for systemic lupus erythematosus?
por: Ding, Shu, et al.
Publicado: (2022)

lncRNAs-EZH2 interaction as promising therapeutic target in cutaneous melanoma
por: Wozniak, Michal, et al.
Publicado: (2023)

MicroRNA-21 Down-regulates Rb1 Expression by Targeting PDCD4 in Retinoblastoma
por: Shen, Fengmei, et al.
Publicado: (2014)

Verification of EZH2 as a druggable target in metastatic uveal melanoma
por: Jin, Bei, et al.
Publicado: (2020)

Targeted Disruption of the EZH2/EED Complex Inhibits EZH2-dependent Cancer
por: Kim, Woojin, et al.
Publicado: (2013)

Adult Onset Retinoblastoma: A Case Report
por: Zhang, Xiao, et al.
Publicado: (2015)

TSPYL2 Regulates the Expression of EZH2 Target Genes in Neurons
por: Liu, Hang, et al.
Publicado: (2018)

Overexpression of EZH2 is associated with the poor prognosis in osteosarcoma and function analysis indicates a therapeutic potential
por: Sun, Ranran, et al.
Publicado: (2016)

Decreased Expression of EZH2 in Granulosa Cells Contributes to Endometriosis-Associated Infertility by Targeting IL-1R2
por: Lin, Xiang, et al.
Publicado: (2022)

Epigenetic regulation of cancer progression by EZH2: from biological insights to therapeutic potential
por: Gan, Lu, et al.
Publicado: (2018)

Adhesion G protein-coupled receptor, ELTD1, is a potential therapeutic target for retinoblastoma migration and invasion
por: Guihurt Santiago, Jonathan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_c8mv0b1piu0fil28ts4u1v0q4q